Baxter International scored an exit as dialysis machine developer Outset Medical floated above its range in an upsized offering.
Outset Medical, a US-based dialysis system provider backed by medical device manufacturer Baxter International, is going public today in an initial public offering sized at approximately $242m.
The IPO will consist of 8.95 million shares issued on the Nasdaq Global Select Market and priced at $27.00 each, above the $22 to $24 range the company had set. It also increased the number of shares in the offering from 7.6 million, and the price values it at about $1.1bn.
Originally founded…
